These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 31570695
1. Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia. Kumar V, Ailawadhi S, Bojanini L, Mehta A, Biswas S, Sher T, Roy V, Vishnu P, Marin-Acevedo J, Alegria VR, Paulus A, Aulakh S, Iqbal M, Manochakian R, Tan W, Chanan-Khan A, Ailawadhi M. Blood Cancer J; 2019 Sep 30; 9(10):75. PubMed ID: 31570695 [Abstract] [Full Text] [Related]
2. Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019. van der Straten L, Levin MD, Dinnessen MAW, Visser O, Posthuma EFM, Doorduijn JK, Langerak AW, Kater AP, Dinmohamed AG. Blood Cancer J; 2023 Jan 13; 13(1):15. PubMed ID: 36635262 [Abstract] [Full Text] [Related]
3. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study. Giri S, Bhatt VR, Verma V, Pathak R, Bociek RG, Vose JM, Armitage JO. Clin Lymphoma Myeloma Leuk; 2017 Sep 13; 17(9):569-574. PubMed ID: 28709798 [Abstract] [Full Text] [Related]
7. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study. Guan X, Jin Y, Chen Y, Jiang Z, Liu Z, Zhao Z, Yan P, Wang G, Wang X. PLoS One; 2015 Nov 13; 10(11):e0143067. PubMed ID: 26571301 [Abstract] [Full Text] [Related]
8. Increased risk of chronic lymphocytic leukaemia among cancer survivors in the Netherlands: increased detection, causal factors or both? van den Broek EC, Liu L, Posthuma EF, Janssen-Heijnen ML, Coebergh JW, Soerjomataram I. Ann Hematol; 2014 Jan 13; 93(1):157-62. PubMed ID: 24381068 [Abstract] [Full Text] [Related]
9. Assessment of second primary malignancies among treated and untreated patients with chronic lymphocytic leukemia using real-world data from the USA. Ailawadhi S, Ravelo A, Ng CD, Shah B, Lamarre N, Wang R, Eakle K, Biondo JM. J Comp Eff Res; 2024 Feb 13; 13(2):e230119. PubMed ID: 38294335 [Abstract] [Full Text] [Related]
10. A population level analysis of second hematological malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma survivors in the era of targeted therapies. Mishra R, Dima D, Kumar SA, Mian A, Taneja A, Karna R, Caimi PF, Hill BT, Dean R, Jagadeesh D. Hematol Oncol; 2023 Dec 13; 41(5):884-893. PubMed ID: 37309225 [Abstract] [Full Text] [Related]
14. Risk of second primary malignancies of adolescent and young adult patients with germ cell cancer: A US population-based analysis. Jiang S, Jiang H, Sun L, Luo Z. Curr Probl Cancer; 2021 Apr 13; 45(2):100641. PubMed ID: 32928566 [Abstract] [Full Text] [Related]
19. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study. Spanogle JP, Clarke CA, Aroner S, Swetter SM. J Am Acad Dermatol; 2010 May 13; 62(5):757-67. PubMed ID: 20223559 [Abstract] [Full Text] [Related]
20. Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma. Kumar V, Garg M, Chandra AB, Mayorga VS, Ahmed S, Ailawadhi S. Clin Lymphoma Myeloma Leuk; 2018 Sep 13; 18(9):576-589.e1. PubMed ID: 29934060 [Abstract] [Full Text] [Related] Page: [Next] [New Search]